| scholarly article | Q13442814 |
| P50 | author | Sylvia Wassertheil-Smoller | Q30002263 |
| Na-Jin Park | Q59681837 | ||
| Lewis Kuller | Q88077314 | ||
| Rowan T Chlebowski | Q89795128 | ||
| Yvette P. Conley | Q89899888 | ||
| Marcia L. Stefanick | Q109542605 | ||
| P2093 | author name string | G J van Londen | |
| Yuefang Chang | |||
| Catherine Bender | |||
| Randi Foraker | |||
| P2860 | cites work | Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level | Q26864094 |
| Menopausal hormone therapy and breast cancer mortality: clinical implications | Q27022201 | ||
| Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society | Q27347760 | ||
| Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention | Q33574045 | ||
| The surveillance, epidemiology, and end results program: a national resource | Q33804988 | ||
| Comorbidities and cardiovascular disease risk in older breast cancer survivors | Q33810528 | ||
| Subclinical Cardiovascular Disease and Death, Dementia, and Coronary Heart Disease in Patients 80+ Years. | Q33886346 | ||
| Follow-up care experiences and perceived quality of care among long-term survivors of breast, prostate, colorectal, and gynecologic cancers | Q33890501 | ||
| Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older | Q34141839 | ||
| The Women's Health Initiative recruitment methods and results | Q34272010 | ||
| The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures | Q34272017 | ||
| Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials | Q34486930 | ||
| Mammography interval and breast cancer mortality in women over the age of 75 | Q34782392 | ||
| Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study | Q35558114 | ||
| Lifestyle interventions for cardiovascular risk reduction in women with breast cancer | Q35878469 | ||
| Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study | Q36207305 | ||
| Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer | Q36637777 | ||
| Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. | Q36887091 | ||
| Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials | Q37015628 | ||
| Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? | Q37131112 | ||
| Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality | Q37275519 | ||
| Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer | Q37350526 | ||
| Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements | Q37375850 | ||
| Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis | Q37899689 | ||
| Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). | Q37999119 | ||
| Personalizing cardiovascular disease prevention among breast cancer survivors. | Q38032942 | ||
| Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women's Health Initiative | Q38543496 | ||
| Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States | Q38776116 | ||
| Patterns and Trends in Age-Specific Black-White Differences in Breast Cancer Incidence and Mortality - United States, 1999-2014. | Q39295570 | ||
| A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer | Q39299117 | ||
| Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group | Q39513392 | ||
| Deaths: Leading Causes for 2014. | Q39633281 | ||
| Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity | Q40280431 | ||
| Breast cancer treatment guidelines in older women. | Q40449859 | ||
| Risk of ischemic heart disease in women after radiotherapy for breast cancer | Q43615460 | ||
| Relation of physical activity to cardiovascular disease mortality and the influence of cardiometabolic risk factors | Q43703256 | ||
| Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer | Q44490665 | ||
| Adult weight change and risk of postmenopausal breast cancer | Q47330282 | ||
| Design of the Women’s Health Initiative Clinical Trial and Observational Study | Q56483522 | ||
| Breast cancer | Q57117791 | ||
| Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics | Q57568345 | ||
| Severe obesity, heart disease, and death among white, african american, and hispanic postmenopausal women | Q57616749 | ||
| Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer | Q63365933 | ||
| Walking compared with vigorous exercise for the prevention of cardiovascular events in women | Q74735768 | ||
| Outcomes ascertainment and adjudication methods in the women's health initiative | Q79202519 | ||
| Long-term risk of cardiovascular disease in 10-year survivors of breast cancer | Q79887212 | ||
| The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study | Q83341212 | ||
| Self-reported diabetes is a valid outcome in pragmatic clinical trials and observational studies | Q84077562 | ||
| ABCDE steps to prevent heart disease in breast cancer survivors | Q86155363 | ||
| Recreational physical activity and leisure-time sitting in relation to postmenopausal breast cancer risk | Q86478276 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease in women | Q105047283 |
| P304 | page(s) | e0184174 | |
| P577 | publication date | 2017-09-21 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative | |
| P478 | volume | 12 |
| Q93152835 | Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer |
| Q48234841 | Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative. |
| Q57020338 | Changes in cardiovascular disease risk and risk factors among women with and without breast cancer |
| Q60912866 | Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy |
| Q57113398 | Physical Activity and Breast Cancer: an Opportunity to Improve Outcomes |
| Q89850801 | Physical activity and quality of life in African American cancer survivors: The Detroit Research on Cancer Survivors study |
| Q91832458 | Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer |
| Q49984892 | The connection between the breast and heart in a woman: Breast cancer and cardiovascular disease. |
Search more.